FDA clears Novus's hernia repair mesh
This article was originally published in Clinica
Executive Summary
The TIGR Matrix surgical mesh developed by Novus Scientific has gained 510(k) clearance from the US FDA. The resorbable mesh can now be used to reinforce soft tissues, the Singapore company says. The matrix is knitted from two different resorbable fibres that degrade at different rates following implantation, and has a macroporous structure designed to allow tissue integration. The product will be used to treat inguinal hernia patients initially, and could be used in ventral and incisional hernia in future.